Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | W026152 | OT |
No symptoms reported.; Customer called to report expired GARDASIL 9 administered to a patient post product expiration. Expiration date was 29JAN2025. Product was administered on 07FEB2025.; This spontaneous report was received from a nurse and refers to a 25-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-FEB-2025, the patient was vaccinated with an expired second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) 0.5 milliliters (mL) administered intramuscularly, lot #W026152; which has been verified to be valid lot number for Human Papillomavirus 9-valent Vaccine, Recombinant, expiration date reported and upon internal validation establish as 29-JAN-2025 (strength and anatomical site of administration were not reported) administered for Prophylaxis (Expired product administered). No temperature excursion occurred. No symptoms reported (No adverse event).